Journal of Gynecologic Oncology
Korean Society of Gynecologic Oncology · KR · ISSN 20050380
What the numbers say
Per-paper citedness has softened while the journal publishes a bit more.
Field-weighted citation impact moved from 2.37 to 1.93. Expect somewhat lower average citation reach for new items compared with before. The share of top-10% cited papers moved from 37.4% to 19.7%. Fewer articles now land among the field's most-cited, so high-citation placement is less common. Cervical Cancer and HPV Research rose from 5.6% to 10.4% of what the journal runs. If your work is on cervical cancer or HPV, the journal is publishing more of that area. Authors from CN went from 25.7% to 31.8%. Submissions from China are becoming a larger share of the content, so regional representation is shifting.
Citation metrics
Based on the Scopus and OpenAlex citation graphs. We do not provide Clarivate’s JCR Impact Factor.
Output and citation impact
Whether citation performance keeps up as output grows.
Topic shift
Share in the last 24 months (2024-09 – 2026-08) versus the previous 24 (2022-09 – 2024-08).
- Cervical Cancer and HPV Research5.6%→10.4%+4.9%pPrevNow
- Ovarian cancer diagnosis and treatment18.8%→23.4%+4.6%pPrevNow
- Endometrial and Cervical Cancer Treatments46.2%→40.8%−5.4%pPrevNow
Terms appearing more often
Wording in recent paper titles that stands out against the journal's own baseline.
Author countries
Last 24 months (2024-09 – 2026-08) against the previous 24 (2022-09 – 2024-08).
- CN25.7%→31.8%+6.1%pPrevNow
- JP21.7%→22.0%+0.2%pPrevNow
- KR24.1%→20.8%−3.3%pPrevNow
- US15.0%→10.2%−4.8%pPrevNow
- TW4.7%→5.1%+0.4%pPrevNow
- TH0.0%→4.3%+4.3%pPrevNow
Top 5 institutions
Top 5 institutions publishing in this journal, 2018 – 2026.
Recently published
20The 20 most recent papers — not the full list.
Most cited
20Top 20 most cited, 2018 – 2026.
Similar journals
Check your draft against this journal
Start free with Nubint AI — citation checks and a peer-review simulation.
Data as of 2026-09-05